1st Quarter - Report

RYAN MACKINNON VASAPOLI AND BERZOK, LLP for GENENTECH

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues regarding follow on biologics, H.R. 5629 Pathway for Biosimilars Act; S. 1695 Biologics, Price Competition and Innovation Act of 2007

LobbyistCovered position, as disclosed
MATTHEW BERZOK —
RODNEY HOPPE —
JEFF MACKINNON —
DOUGLAS R NAPPI —
GEORGE C O'CONNOR —
WILLIAM D PHILLIPS —
THOMAS RYAN —
JOSEPH V VASAPOLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1695 (110th), H.R. 5629 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.